U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07011797) titled 'A Study to Evaluate the Efficacy and Safety of CX11 Tablets in Overweight/Obese Participants' on June 02.
Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled Phase 2 clinical study:
* To evaluate the efficacy of different dose levels of CX11 tablets in body weight reduction as compared to placebo.
* To compare the changes of effects in weight and weight-related indicators at the visit time points.
* To evaluate the tolerability and safety of different doses of CX11 tablets in overweight/obese participants.
* To assess the pharmacokinetics (PK) of different doses of CX11 tablets in overweight/obese ...